Thermo Scientific™ AcroMetrix™ Multi-Analyte ctDNA Plasma Control A - E (RUO)

Description

• Validate and assess run-to-run assay variation of ctDNA somatic mutation panels
• Intended for use with next generation sequencing (NGS), qualitative/quantitative PCR assays designed to identify somatic mutations in DNA from liquid biopsy samples
• For research use only
• Normal human plasma matrix: Exceptional DNA recovery for confident verification of extraction procedures 5 variant allele frequencies Accurate identification of 13 variants (including SNV, INDEL, and CNV variant types) Broad range of cancer types Breast, colon, lung, ovaries, pancreas, skin, thyroid, and more Verified for research use Validated on droplet digital PCR and amplicon-based NGS platforms FAQs Why Do We Need Quality Controls for Oncology Assays? What is the Role of Circulating Tumor DNA Reference Materials in the Field of Liquid Biopsy? Where can I access more of AcroMetrix RUO solutions? Is there an e-commerce portal for web-orderable products?